Diabetes Neuromathix (DNx) uses entirely new paradigms of evolutionary ML and adversarial AI to bring stable control to users of artificial pancreases with Type 1 diabetes. ~ 56% of Type 1 diabetes patients struggle with high / very high ‘glycaemic variability’. Poor blood glucose control diminish...See more
Headquarters:
Australia
Company Type:
SME
Company size:
1-10 Employees
Address:
BRISBANE, QUEENSLAND, AU
LOW
spending power